 | | | | Spain reported its first monkeypox-related death on Friday, in what is thought to be Europe's first death from the disease and only the second outside of Africa in the current outbreak. | | | | | | Germany's Alexandra Popp may be playing in her first women's European Championship final when they take on hosts England but she has shown no signs of nerves, fulfilling her media duties with a fake moustache in response to a joke by a German magazine. | | | | | | AbbVie Inc has agreed to pay up to $2.37 billion to resolve thousands of U.S. lawsuits against its Allergan unit over the marketing of opioid painkillers, state officials announced on Friday. | | | | | | The White House will host the inaugural meeting of pro bono attorneys and activists who defend abortion rights on Friday, in the wake of the U.S. Supreme Court's overturning of Roe v Wade last month. | | | | | | The U.S. government said on Friday it agreed to a $1.74 billion deal for 66 million doses of a Moderna Inc COVID vaccine updated for the Omicron subvariant for use in a fall and winter booster campaign, sending Moderna shares up 3%. | | | | | | Brazil on Friday reported the first monkeypox-related death outside the African continent in the current outbreak, shortly before Spain confirmed Europe's first known death in the outbreak later in the day. | | | | | | British drugmaker GSK has struck a deal to allow low-cost generic versions of its long-acting HIV preventive medicine to be used in the developing world, including sub-Saharan Africa where the virus remains a leading cause of death. | | | | | | Long-serving AstraZeneca boss Pascal Soriot said on Friday he expects to work with the new chairman-designate of the London-listed drugmaker, who will take over in 2023, for many years to come, suggesting he is not ready to retire. | | | | | | Bristol Myers Squibb said on Friday a trial evaluating a combination of its two cancer drugs failed to meet the primary goal to treat localized kidney cancer. | | | | | | People at high risk of severe disease who have yet to get a second COVID-19 booster should not wait for next-generation, Omicron-targeted vaccines expected in the fall, five vaccine experts told Reuters. | | | | | |
